Log Ki xamoterol | n | Log Ki nebivolol | n | |
---|---|---|---|---|
β1-WT | −7.19 ± 0.04 | 25 | −8.33 ± 0.05 | 14 |
β1-N | −7.10 ± 0.11 | 5 | −8.18 ± 0.11 | 10 |
β1-EL1 | −7.38 ± 0.08 | 5 | −8.35 ± 0.07 | 10 |
β1-EL2 | −7.01 ± 0.11 | 5 | −8.11 ± 0.09 | 10 |
β1-EL3 | −7.41 ± 0.13 | 5 | −8.10 ± 0.09 | 10 |
β1-TM1 | −7.31 ± 0.08 | 8 | −8.53 ± 0.04 | 6 |
β1-TM2 | −6.35 ± 0.05**** | 8 | −7.32 ± 0.07**** | 6 |
β1-TM3 | −7.17 ± 0.08 | 8 | −8.15 ± 0.09 | 6 |
β1-TM4 | −7.41 ± 0.08 | 8 | −7.91 ± 0.09* | 6 |
β1-TM5 | −7.24 ± 0.08 | 8 | −8.28 ± 0.05 | 6 |
β1-TM6 | −6.97 ± 0.09 | 7 | −7.93 ± 0.05* | 6 |
β1-TM7 | −6.89 ± 0.10 | 7 | −8.06 ± 0.06 | 6 |
β2-WT | −5.89 ± 0.03 | 30 | −6.93 ± 0.06 | 12 |
β2-N | −5.97 ± 0.11 | 8 | −6.89 ± 0.08 | 10 |
β2-EL1 | −5.85 ± 0.04 | 8 | −7.05 ± 0.04 | 10 |
β2-EL2 | −6.06 ± 0.05 | 8 | −6.82 ± 0.05 | 9 |
β2-EL3 | −5.91 ± 0.06 | 8 | −7.15 ± 0.07 | 10 |
β2-TM1 | −5.85 ± 0.04 | 8 | −7.05 ± 0.06 | 6 |
β2-TM2 | −6.84 ± 0.07**** | 7 | −7.74 ± 0.12**** | 6 |
β2-TM3 | −6.01 ± 0.07 | 8 | −6.76 ± 0.03 | 6 |
β2-TM4 | −5.68 ± 0.04 | 7 | −6.90 ± 0.03 | 6 |
β2-TM5 | −5.89 ± 0.03 | 6 | −6.95 ± 0.02 | 6 |
β2-TM6 | −6.09 ± 0.05 | 7 | −6.91 ± 0.05 | 6 |
β2-TM7 | −6.23 ± 0.04*** | 9 | −6.97 ± 0.08 | 6 |
β1-selectivity | 20.0 | 25.1 |
****P < 0.000001 One-way ANOVA with post hoc Tukey comparing values from the mutant receptors with those obtained from the β1-WT or the β2-WT.
***P < 0.00003 and *P < 0.05 compared with β1-WT or the β2-WT.